BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, June 11, 2026
Home » Topics » Infection » Coronavirus

Coronavirus
Coronavirus RSS Feed RSS

Regulatory actions for Aug. 17, 2020

Aug. 17, 2020
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Baxter.
Read More

Other news to note for Aug. 17, 2020

Aug. 17, 2020
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Angiodynamics, Anthem, Avateramedical, Brain Scientific, Carterra, Endospan, Forwardttc, Genmark Diagnostics, Hengrui Therapeutics, Magle Chemoswed, Microbot Medical, Quest Diagnostics, Sectra, Sirtex Medical, Swift Biosciences, Thermo Fisher Scientific, Tissue Regenix Group, Todos Medica.
Read More
Coronavirus microscopic model

CNBG unveils interim data of inactivated vaccine candidate for COVID-19

Aug. 17, 2020
By Elise Mak
Chinese state-backed vaccine developer China National Biotec Group (CNBG), of Beijing, published an interim analysis of randomized phase I/II trials of its inactivated SARS-CoV-2 vaccine candidate in the Journal of the American Medical Association last week.
Read More
R&D money

Biopharmas continue to ramp up their R&D investments, analysis finds

Aug. 17, 2020
By Peter Winter
According to an analysis conducted by BioWorld of the second-quarter 2020 financial reports filed by 120 public biopharmaceutical companies with market caps greater than $1 billion, and excluding big pharma companies, the amount that was invested in research and development during the period increased by 14% compared to the same six-month period last year.
Read More

ICYMI: Week in Review, Aug. 10-14, 2020

Aug. 17, 2020
By Peter Winter
A quick look back at top stories.
Read More

Regulatory front for Aug. 17, 2020

Aug. 17, 2020
The latest global regulatory news, changes and updates affecting biopharma.
Read More

Other news to note for Aug. 17, 2020

Aug. 17, 2020
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Abeona, Adgero, Aicuris, Alnylam, Arvelle, Bioaegis, BMS, Bold, Boundless Bio, Carsgen, Dragonfly, Delmar, Enzon, Hengrui, Hifibio, Kiadis, Memo, Organovo, Ose, Pluristem, Taysha, Thermo Fisher, Xbiotech.
Read More

In the clinic for Aug. 17, 2020

Aug. 17, 2020
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alkermes, Amplyx, Ansun, Ascletis, Axcella, Azurrx, Betagenon/Balticgruppen, Chiasma, Clovis, Enterprise, GNI Group, I-Mab, Merck, Neuroptika, Novavax, Precigen, Syndax, Unity.
Read More

Regulatory actions for Aug. 14, 2020

Aug. 17, 2020
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Adamis, Kempharm, Mesoblast, TLC, Verona.
Read More

European Commission’s first COVID-19 deal goes to Astrazeneca while Novavax signs U.K agreement

Aug. 14, 2020
By Lee Landenberger
Astrazeneca plc is the first company to sign an agreement with the European Commission to supply a COVID-19 vaccine.
Read More
Previous 1 2 … 392 393 394 395 396 397 398 399 400 … 552 553 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 11, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for June 9, 2026
  • 3D rendering of β2-Adrenergic receptor GPCR protein molecule embedded in lipid bilayer membrane.

    Skape Bio unlocks GPCR targets with de novo-designed miniproteins

    BioWorld
    Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
  • Wuxi Apptec signage

    Wuxi Apptec insists it’s ‘not a Chinese military company’

    BioWorld
    Wuxi Apptec isn’t going down without a fight after the U.S. Department of Defense added it to the Section 1260H list June 8 as a designated “Chinese military...
  • Hands holding paper

    Researchers hit back after colleagues removed from ADA meeting

    BioWorld
    Former principal officers of the American Diabetes Association (ADA) have hit back at the association’s board and CEO after it prohibited the distribution of an...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing